Xiaoping Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Cancer-related gene regulation
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 18
- Cancer-related gene regulation 8
- RNA Research and Splicing 5
- Advanced biosensing and bioanalysis techniques 4
- Circular RNAs in diseases 4
-
- Cancer-related molecular mechanisms research 18
- Cancer, Hypoxia, and Metabolism 13
- MicroRNA in disease regulation 6
- Co-authors
- Bixiang Zhang (28 shared papers)Zhibin Liao (12 shared papers)Limin Xia (9 shared papers)Bixiang Zhang (5 shared papers)Wenjie Huang (8 shared papers)Mengyu Sun (8 shared papers)Huifang Liang (10 shared papers)Yijun Wang (6 shared papers)
- Journals
- Oncogene (3 papers)Biomarker Research (3 papers)Cell Death and Disease (3 papers)Cell Death Discovery (3 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Xiaoping Chen
88 papers receiving 1.8k citations
Xiaoping Chen's Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 561
- Molecular Biology 923
- Oncology 264
- Immunology 211
- Hepatology 52
Countries citing papers authored by Xiaoping Chen
This map shows the geographic impact of Xiaoping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Chen more than expected).
Fields of papers citing papers by Xiaoping Chen
This network shows the impact of papers produced by Xiaoping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Chen. The network helps show where Xiaoping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 124 | |
| 2 | 2010 | 93 | |
| 3 | 2022 | 91 | |
| 4 | 2023 | 78 | |
| 5 | 2022 | 71 | |
| 6 | 2010 | 67 | |
| 7 | 2014 | 63 | |
| 8 | 2022 | 50 | |
| 9 | 2022 | 48 | |
| 10 | 2014 | 46 | |
| 11 | Cancer stem cells and niches: challenges in immunotherapy resistance Hit paper breakdown → | 2025 | 44 |
| 12 | 2022 | 41 | |
| 13 | 2021 | 40 | |
| 14 | 2010 | 37 | |
| 15 | 2022 | 35 | |
| 16 | 2022 | 31 | |
| 17 | 2018 | 30 | |
| 18 | 2019 | 30 | |
| 19 | 2014 | 28 | |
| 20 | 2021 | 27 |
About Xiaoping Chen
Xiaoping Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Genetics and Biomedical Engineering, having authored 92 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (18 papers), Cancer, Hypoxia, and Metabolism (13 papers), Cancer-related gene regulation (8 papers), MicroRNA in disease regulation (6 papers), RNA Research and Splicing (5 papers), Advanced biosensing and bioanalysis techniques (4 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Cancer Research (561 citations), Molecular Biology (923 citations), Oncology (264 citations), Immunology (211 citations) and Hepatology (52 citations). Xiaoping Chen has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Bixiang Zhang, Zhibin Liao, Limin Xia, Bixiang Zhang, Wenjie Huang, Mengyu Sun, Huifang Liang, Yijun Wang, Tongyue Zhang and Danfei Liu. Their work appears in journals such as Oncogene, Biomarker Research, Cell Death and Disease, Cell Death Discovery and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.